3-substituted anilines as scaffolds for the construction of glutamine synthetase and DXP-reductoisomerase inhibitors

Synthetic Communications

Volumn 39, Issue 15, 2009, Pages 2723-2736

  Mutorwa, Marius ^a   Salisu, Sheriff ^a   Blatch, Gregory L ^a   Kenyon, Colin ^b   Kaye, Perry T ^a  

^a RHODES UNIVERSITY   (South Africa)

^b CSIR Bio/Chemtek   (South Africa)

Author keywords

Aniline derivatives; DXP reductoisomerase inhibitors; Glutamine synthetase; Phosphonates

Indexed keywords

1 DEOXY 1 DEXTRO XYLULOSE 5 PHOSPHATE REDUCTIOISOMERASE INHIBITOR; 3 AMINOPHENOL; ADENOSINE TRIPHOSPHATE DERIVATIVE; ANILINE DERIVATIVE; CHLORIDE; CHLOROACETYL CHLORIDE; ENZYME INHIBITOR; ISOMERASE INHIBITOR; LIGASE INHIBITOR; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ACETYLATION; ACYLATION; ALKYLATION; ARBUZOV REACTION; ARTICLE; DRUG STRUCTURE; ENZYME INHIBITION; NONHUMAN; REACTION ANALYSIS;

EID: 67650340478     PISSN: 00397911     EISSN: 15322432     Source Type: Journal    
DOI: 10.1080/00397910802663444     Document Type: Article

References (23)

1. Beers, M. H.; Berkow, R. The Merck Manual of Diagnosis and Therapy, 7th ed.; Merck & Co., Inc.: Whitehouse Station, NJ, 1999; p. 1193;
2. (b) Kim, J. Y.; Shakow, A.; Mate, K.; Vanderwarker, C.; Gupta, R.; Farmer, P. Limited good and limited vision: Multidrug-resistant tuberculosis and global health policy. Soc. Sci. Med. 2005, 61 (4), 847-859.
3. Raynaud, C.; Etienne, G.; Peyron, P.; Lanéelle, M.; Daffé, M. Extracellular enzyme activities potentially involved in the pathogenicity of Mycobacterium tuberculosis. Microbiology 1998, 144, 577-587.
4. Harth, G.; Horwitz, M. A. Expression and efficient export of enzymically active Mycobacterium tuberculosis glutamine synthetase in Mycobacterium smegmatis and evidence that the information for export is contained within the protein. J. Biol. Chem. 1997, 272 (36), 22728-22735.
5. Harth, G.; Horwitz, M. A. J. An inhibitor of exported Mycobacterium tuberculosisglutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: Extracellular proteins as potential novel drug targets. Exp. Med. 1999, 189 (9), 1425-1435.
6. Harth, G.; Clemens, D. L.; Horwitz, M. A. Glutamine synthetase of Mycobacterium tuberculosis: Extracellular release and characterization of its enzymic activity. Proc. Natl. Acad. Sci. USA 1994, 91 (20), 9342-9346.
7. Hirschfield, G. R.; McNeil, M.; Brennan, P. J. Peptidoglycan-associated polypeptides of Mycobacterium tuberculosis. J. Bacteriol. 1990, 172 (2), 1005-1013.
8. Eisenberg, D.; Gill, H. S.; Pfluegl, G. M. U.; Rotstein, S. H. Structure- function relationships of glutamine synthetases. Biochim. Biophys. Acta.2000, 1477 (1-2), 122-145.
9. Salisu, S. T. ATP Mimics as Glutamine Synthetase Inhibitors-An Exploratory Synthetic Study (PhD Thesis, Rhodes University, 2008).
10. Jomaa, H.; Wiesner, J.; Sanderbrand, S.; Altincicek, B.; Weidemeyer, C.; Hintz, M.; Turbachova, I.; Eberl, J.; Zeidler, J.; Lichtenthaler, H. K.; Soldati, D.; Beck, E. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 1999, 285 (5433), 1573-1576.
11. Reichenberg, A.; Wiesner, J.; Weidemeyer, C.; Dreiseidler, E.; Sanderbrand, S.; Altincicek, B.; Beck, E.; Schlitzer, M.; Jomaa, H. Diaryl ester prodrugs of FR900098 with improved in vivo antimalarial activity. Bioorg. Med. Chem. Lett. 2001, 11 (6), 833-835.
12. HOSE code prediction. http://www.modgraph.co.uk/product-nmr-HOSE. htm (accessed December 20, 2007).
13. Robins, M. J.; Hatfield, P. W. Nucleic acid related compounds, 38: Smooth and high-yield iodination and chlorination at C-5 of uracil bases and ptolyl- protected nucleosides. Can. J. Chem. 1982, 60 (5), 547-553.
14. Thomas, B. N.; Lindermann, C. M.; Corcoran, R. C.; Cotant, C. L.; Kirsch, J. E.; Persichini, P. J. Phosphonate lipid tubules II. J. Am. Chem. Soc. 2002, 124 (7), 1227-1233.
15. 13C-labeled disaccharide ligand. Can. J. Chem. 2002, 80 (8), 904-907.
16. Jacobs, W. A.; Heidelberger, M. The quaternary salts of hexamethylenetetramine, III: Monohalogenacylated aromatic amines and their hexamethylenetetraminium (hexamethylenetetrammonium) salts. J. Bio. Chem. 1915, 21, 103-143.
17. Matulenko, M. A.; Hakeem, A. A.; Kolasa, T.; Nakane, M.; Terranova, M. A.; Uchic, M. E.; Miller, L. N.; Chang, R.; Donnelly-Roberts, D. L.; Namovic, M. T.; Moreland, R. B.; Brioni, J. D.; Stewart, A. O. Synthesis and functional activity of (2-aryl-1-piperazinyl)-N-(3-methylphenyl)acetamides: Selective dopamine D4 receptor agonists. Bioorg. Med. Chem. 2004, 12 (13), 3471-3483.
18. Khanna, S.; Madan, M.; Vangoori, A.; Banerjee, R.; Thaimattam, R.; Basha, S. K. J. S.; Ramesh, M.; Casturi, S. R.; Pal, M. Evaluation of glycolamide esters of indomethacin as potential cyclooxygenase-2 (COX-2) inhibitors. Bioorg. Med. Chem. 2006, 14 (14), 4820-4833.
19. Bhatia, P. A.; Daanen, J. F.; Hakeem, A. A.; Kolasa, T.; Matulenko, M. A.; Mortell, K. H.; Patel, M. V.; Stewart, A. O.; Wang, X.; Xia, Z.; Zhang, H. Q. Preparation of piperazinyl, piperidinyl, and related acetamides and benzamides as dopamine D4 receptor agonists useful in treating sexual dysfunction. U.S. Pat. Appl. Publ., US2004029887 A1 20040212, 2004. Cont.-in-part of U.S. Ser. No. 154,373.
20. Desai, A. D.; Chikhalia, K. H. Synthesis and studies of N-aryl-2-[4- (4-methyl-1-piperazinyl)anilino]acetamides. E-J. Chem. 2005, 2 (6), 15-20.
21. Nakao, N.; Ohashi, K.; Ogihara, T.; Okano, A.; Matsumura, Y.; Nakano, T. Therapeutic agent for urinary incontinence. PCT Int. Appl., WO 2003063852 A1 20030807, 2003.
22. Ando, K.; Tsuji, E.; Ando, Y.; Kunitomo, J.-I.; Kobayashi, R.; Yokomizo, T.; Shimizu, T.; Yamashita, M.; Ohta, S.; Nabe, T.; Kohno, S.; Ohishi, Y. Synthesis of 2-, 4-, and 5-(2-alkylcarbamoyl-1-methylvinyl)-7-alkyloxybenzo[ b]furans and their leukotriene B4 receptor antagonistic activity. Org. Biomol. Chem. 2005, 3 (11), 2129-2139.
23. Braune, C. E.; Cook, C. D. 2,3,4,5,6-Penta-O-acetyl-D-ηluconic acid and 2,3,4,5,6-penta-O-acetyl-d-ηluconyl chloride. Org. Synth. 1961, 41, 79-82.